What is the expected CAGR for the market during the forecast period 2025 - 2035?

The expected CAGR for the Health Economics and Outcomes Research Service Market during the forecast period 2025 - 2035 is 8.61%. Read More

Which therapeutic area is projected to have the highest market value by 2035?

The oncology therapeutic area is projected to reach a market value of 3.5 USD Billion by 2035. Read More

What are the key segments of the Health Economics and Outcomes Research Service Market?

Key segments include Health Economic Modeling, Outcomes Research, Market Access Strategy, and Value Dossier Development. Read More

Which client type is expected to dominate the market by 2035?

Pharmaceutical companies are expected to dominate the market, with a projected value of 4.12 USD Billion by 2035. Read More

What is the projected market value for Real-World Evidence Studies by 2035?

The projected market value for Real-World Evidence Studies is 3.29 USD Billion by 2035. Read More

Who are the leading players in the Health Economics and Outcomes Research Service Market?

Leading players include IQVIA, Optum, Cerner Corporation, and McKesson Corporation. Read More

What is the projected market value for Budget Impact Analysis by 2035?

The projected market value for Budget Impact Analysis is 3.1 USD Billion by 2035. Read More

How does the market for Neurology compare to other therapeutic areas by 2035?

The market for Neurology is projected to reach 2.0 USD Billion by 2035, indicating a growing interest in this area. Read More

What is the expected market size of the Global Health Economics and Outcomes Research Service Market by 2035?

By 2035, the Global Health Economics and Outcomes Research Service Market is projected to reach 5.68 USD Billion. Read More

Which region is anticipated to dominate the Global Health Economics and Outcomes Research Service Market in 2024?

North America is anticipated to dominate the market with a value of 1.2 USD Billion in 2024. Read More

What are the expected market values for Europe by 2024 and 2035?

Europe is expected to be valued at 0.9 USD Billion in 2024 and 1.7 USD Billion in 2035. Read More

What is the market size for Cost-Effectiveness Analysis in 2024?

The Cost-Effectiveness Analysis segment is valued at 0.931 USD Billion in 2024. Read More

Which major players are involved in the Global Health Economics and Outcomes Research Service Market?

Key players include Optum, Covance, and IQVIA among others in the Global Health Economics and Outcomes Research Service Market. Read More

What is the market value for Health Technology Assessment in 2024?

The Health Technology Assessment segment is valued at 1.081 USD Billion in 2024. Read More

What is the anticipated market value for South America in 2024 and 2035?

South America is expected to be valued at 0.15 USD Billion in 2024 and 0.3 USD Billion by 2035. Read More

What is the projected market size for Budget Impact Analysis by 2035?

By 2035, the Budget Impact Analysis segment is projected to reach 1.072 USD Billion. Read More

Health Economics And Outcomes Research Service Market

Q: What is the projected market valuation for the Health Economics and Outcomes Research Service Market in 2035?

The projected market valuation for the Health Economics and Outcomes Research Service Market in 2035 is 10.51 USD Billion. Read More

Q: What was the overall market valuation in 2024?

The overall market valuation for the Health Economics and Outcomes Research Service Market was 4.236 USD Billion in 2024. Read More

ID: MRFR/HC/40931-HCR

128 Pages

Rahul Gotadki

Last Updated: April 06, 2026

Global Health Economics and Outcomes Research Service Market Research Report: Size, Share, Trend Analysis By Service Type (Health Economic Modeling, Outcomes Research, Market Research Report: Size, Share, Trend Analysis By Therapeutic Area (Oncology, Cardiovascular, Neurology, Infectious Diseases), By Study Design (Cost-Effectiveness Analysis, Budget Impact Analysis, Real-World Evidence Studies), By Client Type (Pharmaceutical Companies, Biotechnology Firms, Medical Device Companies, Healthcare Providers) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Health Economics And Outcomes Research Service Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)8.61%

2024 Market Size$ 4.24 Billion

2025 Market Size$ 4.6 Billion

2035 Market Size$ 10.51 Billion

Key Players

IQVIA

Optum

Cerner Corporation

McKesson Corporation

PAREXEL International

Covance

Trends

Value-Based Care Adoption
Technological Advancements in Research
Regulatory Demands for Evidence

Opportunities

Focus on Patient-Centered Outcomes
Integration of Real-World Evidence
Increased Collaboration Among Stakeholders

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Type (USD Billion)
  1. 4.1.1 Health Economic Modeling
  2. 4.1.2 Outcomes Research
  3. 4.1.3 Market Access Strategy
  4. 4.1.4 Value Dossier Development
2. 4.2 Healthcare, BY Therapeutic Area (USD Billion)
  1. 4.2.1 Oncology
  2. 4.2.2 Cardiovascular
  3. 4.2.3 Neurology
  4. 4.2.4 Infectious Diseases
3. 4.3 Healthcare, BY Study Design (USD Billion)
  1. 4.3.1 Cost-Effectiveness Analysis
  2. 4.3.2 Budget Impact Analysis
  3. 4.3.3 Real-World Evidence Studies
4. 4.4 Healthcare, BY Client Type (USD Billion)
  1. 4.4.1 Pharmaceutical Companies
  2. 4.4.2 Biotechnology Firms
  3. 4.4.3 Medical Device Companies
  4. 4.4.4 Healthcare Providers
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 IQVIA (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Optum (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Cerner Corporation (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 McKesson Corporation (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 PAREXEL International (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Covance (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Industry expert's Health (GB)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Truist Health (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Analysis Group (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY TYPE
4. 6.4 US MARKET ANALYSIS BY THERAPEUTIC AREA
5. 6.5 US MARKET ANALYSIS BY STUDY DESIGN
6. 6.6 US MARKET ANALYSIS BY CLIENT TYPE
7. 6.7 CANADA MARKET ANALYSIS BY TYPE
8. 6.8 CANADA MARKET ANALYSIS BY THERAPEUTIC AREA
9. 6.9 CANADA MARKET ANALYSIS BY STUDY DESIGN
10. 6.10 CANADA MARKET ANALYSIS BY CLIENT TYPE
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY TYPE
13. 6.13 GERMANY MARKET ANALYSIS BY THERAPEUTIC AREA
14. 6.14 GERMANY MARKET ANALYSIS BY STUDY DESIGN
15. 6.15 GERMANY MARKET ANALYSIS BY CLIENT TYPE
16. 6.16 UK MARKET ANALYSIS BY TYPE
17. 6.17 UK MARKET ANALYSIS BY THERAPEUTIC AREA
18. 6.18 UK MARKET ANALYSIS BY STUDY DESIGN
19. 6.19 UK MARKET ANALYSIS BY CLIENT TYPE
20. 6.20 FRANCE MARKET ANALYSIS BY TYPE
21. 6.21 FRANCE MARKET ANALYSIS BY THERAPEUTIC AREA
22. 6.22 FRANCE MARKET ANALYSIS BY STUDY DESIGN
23. 6.23 FRANCE MARKET ANALYSIS BY CLIENT TYPE
24. 6.24 RUSSIA MARKET ANALYSIS BY TYPE
25. 6.25 RUSSIA MARKET ANALYSIS BY THERAPEUTIC AREA
26. 6.26 RUSSIA MARKET ANALYSIS BY STUDY DESIGN
27. 6.27 RUSSIA MARKET ANALYSIS BY CLIENT TYPE
28. 6.28 ITALY MARKET ANALYSIS BY TYPE
29. 6.29 ITALY MARKET ANALYSIS BY THERAPEUTIC AREA
30. 6.30 ITALY MARKET ANALYSIS BY STUDY DESIGN
31. 6.31 ITALY MARKET ANALYSIS BY CLIENT TYPE
32. 6.32 SPAIN MARKET ANALYSIS BY TYPE
33. 6.33 SPAIN MARKET ANALYSIS BY THERAPEUTIC AREA
34. 6.34 SPAIN MARKET ANALYSIS BY STUDY DESIGN
35. 6.35 SPAIN MARKET ANALYSIS BY CLIENT TYPE
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY THERAPEUTIC AREA
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY STUDY DESIGN
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY CLIENT TYPE
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY TYPE
42. 6.42 CHINA MARKET ANALYSIS BY THERAPEUTIC AREA
43. 6.43 CHINA MARKET ANALYSIS BY STUDY DESIGN
44. 6.44 CHINA MARKET ANALYSIS BY CLIENT TYPE
45. 6.45 INDIA MARKET ANALYSIS BY TYPE
46. 6.46 INDIA MARKET ANALYSIS BY THERAPEUTIC AREA
47. 6.47 INDIA MARKET ANALYSIS BY STUDY DESIGN
48. 6.48 INDIA MARKET ANALYSIS BY CLIENT TYPE
49. 6.49 JAPAN MARKET ANALYSIS BY TYPE
50. 6.50 JAPAN MARKET ANALYSIS BY THERAPEUTIC AREA
51. 6.51 JAPAN MARKET ANALYSIS BY STUDY DESIGN
52. 6.52 JAPAN MARKET ANALYSIS BY CLIENT TYPE
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY THERAPEUTIC AREA
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY STUDY DESIGN
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY CLIENT TYPE
57. 6.57 MALAYSIA MARKET ANALYSIS BY TYPE
58. 6.58 MALAYSIA MARKET ANALYSIS BY THERAPEUTIC AREA
59. 6.59 MALAYSIA MARKET ANALYSIS BY STUDY DESIGN
60. 6.60 MALAYSIA MARKET ANALYSIS BY CLIENT TYPE
61. 6.61 THAILAND MARKET ANALYSIS BY TYPE
62. 6.62 THAILAND MARKET ANALYSIS BY THERAPEUTIC AREA
63. 6.63 THAILAND MARKET ANALYSIS BY STUDY DESIGN
64. 6.64 THAILAND MARKET ANALYSIS BY CLIENT TYPE
65. 6.65 INDONESIA MARKET ANALYSIS BY TYPE
66. 6.66 INDONESIA MARKET ANALYSIS BY THERAPEUTIC AREA
67. 6.67 INDONESIA MARKET ANALYSIS BY STUDY DESIGN
68. 6.68 INDONESIA MARKET ANALYSIS BY CLIENT TYPE
69. 6.69 REST OF APAC MARKET ANALYSIS BY TYPE
70. 6.70 REST OF APAC MARKET ANALYSIS BY THERAPEUTIC AREA
71. 6.71 REST OF APAC MARKET ANALYSIS BY STUDY DESIGN
72. 6.72 REST OF APAC MARKET ANALYSIS BY CLIENT TYPE
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY TYPE
75. 6.75 BRAZIL MARKET ANALYSIS BY THERAPEUTIC AREA
76. 6.76 BRAZIL MARKET ANALYSIS BY STUDY DESIGN
77. 6.77 BRAZIL MARKET ANALYSIS BY CLIENT TYPE
78. 6.78 MEXICO MARKET ANALYSIS BY TYPE
79. 6.79 MEXICO MARKET ANALYSIS BY THERAPEUTIC AREA
80. 6.80 MEXICO MARKET ANALYSIS BY STUDY DESIGN
81. 6.81 MEXICO MARKET ANALYSIS BY CLIENT TYPE
82. 6.82 ARGENTINA MARKET ANALYSIS BY TYPE
83. 6.83 ARGENTINA MARKET ANALYSIS BY THERAPEUTIC AREA
84. 6.84 ARGENTINA MARKET ANALYSIS BY STUDY DESIGN
85. 6.85 ARGENTINA MARKET ANALYSIS BY CLIENT TYPE
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY THERAPEUTIC AREA
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY STUDY DESIGN
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY CLIENT TYPE
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY THERAPEUTIC AREA
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY STUDY DESIGN
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY CLIENT TYPE
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY THERAPEUTIC AREA
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY STUDY DESIGN
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY CLIENT TYPE
99. 6.99 REST OF MEA MARKET ANALYSIS BY TYPE
100. 6.100 REST OF MEA MARKET ANALYSIS BY THERAPEUTIC AREA
101. 6.101 REST OF MEA MARKET ANALYSIS BY STUDY DESIGN
102. 6.102 REST OF MEA MARKET ANALYSIS BY CLIENT TYPE
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY TYPE, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY THERAPEUTIC AREA, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY STUDY DESIGN, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY STUDY DESIGN, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY CLIENT TYPE, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY CLIENT TYPE, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.2.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.2.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.3.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.3.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.4.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.4.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.5.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.5.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.6.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.6.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.7.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.7.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.8.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.8.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.9.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.9.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.10.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.10.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.11.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.11.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.12.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.12.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.13.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.13.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.14.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.14.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.15.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.15.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.16.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.16.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.17.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.17.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.18.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.18.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.19.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.19.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.20.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.20.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.21.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.21.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.22.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.22.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.23.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.23.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.24.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.24.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.25.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.25.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.26.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.26.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.27.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.27.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.28.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.28.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.29.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.29.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  3. 7.30.3 BY STUDY DESIGN, 2025-2035 (USD Billion)
  4. 7.30.4 BY CLIENT TYPE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Health Economics And Outcomes Research Service Market Segmentation

Health Economics And Outcomes Research Service Market By Type (USD Billion, 2025-2035)

Health Economic Modeling
Outcomes Research
Market Access Strategy
Value Dossier Development

Health Economics And Outcomes Research Service Market By Therapeutic Area (USD Billion, 2025-2035)

Oncology
Cardiovascular
Neurology
Infectious Diseases

Health Economics And Outcomes Research Service Market By Study Design (USD Billion, 2025-2035)

Cost-Effectiveness Analysis
Budget Impact Analysis
Real-World Evidence Studies

Health Economics And Outcomes Research Service Market By Client Type (USD Billion, 2025-2035)

Pharmaceutical Companies
Biotechnology Firms
Medical Device Companies
Health Economics And Outcomes Research Service Market Providers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035